Urinary Bladder Neck Obstruction
Showing 26 - 50 of >10,000
Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD)
Completed
- Urinary Incontinence
- Tolterodine ER 4 mg QD
- Tamsulosin 0.4 mg QD
-
Birmingham, Alabama
- +94 more
Jan 26, 2021
Quantifying Systemic Immunosuppression to Personalize Cancer
Recruiting
- Melanoma
- +6 more
- MDSC quantification
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022
Prostate Cancer, Urinary Incontinence, Surgery Trial in Baltimore (Augmented Bladder Neck Reconstruction, Standard Bladder Neck
Terminated
- Prostate Cancer
- +2 more
- Augmented Bladder Neck Reconstruction
- Standard Bladder Neck Reconstruction
-
Baltimore, MarylandJohns Hopkins Hospital
Mar 15, 2021
BPH, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms, BPH Without Urinary Obstruction Trial in Virginia
Completed
- BPH
- +8 more
- MenHealth Uroflowmeter
-
Virginia Beach, VirginiaUrology of Virginia
Mar 1, 2021
Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules
Recruiting
- Neoplasms
- +13 more
- HTL0039732 Capsules
- HTL0039732 Capsules and atezolizumab infusion
-
Cambridge, United Kingdom
- +4 more
Jul 5, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,
Recruiting
- Lung Cancer Non Small Cell
- +2 more
- IO102-IO103 in combination with pembrolizumab
-
Duarte, California
- +18 more
Dec 15, 2022
Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +4 more
-
Aurora, Colorado
- +2 more
Apr 18, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York
Recruiting
- Advanced Solid Tumor
- +13 more
- [225Ac]-FPI-1966
- +2 more
-
Duarte, California
- +3 more
Oct 25, 2022
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Intravesical Prostatic Protrusion Mimicking Urothelial Cell
Recruiting
- Bladder Cancer
- +2 more
- Urethrocystoscopy
-
Ankara, Altindag, TurkeyAnkara Training and Research Hospital
Feb 28, 2022
Advanced Solid Tumor, Metastatic Solid Tumor, NSCLC Trial in Suwon-si, Daejeon, Seoul (GI-101, Pembrolizumab, Lenvatinib)
Recruiting
- Advanced Solid Tumor
- +7 more
- GI-101
- +3 more
-
Suwon-si, Kyeonggi-do, Korea, Republic of
- +3 more
Apr 19, 2022
Male Urogenital Diseases, Genital Diseases, Male, Prostatic Disease Trial in Hialeah (SoracteLite(TM) TPLA for BPH)
Active, not recruiting
- Male Urogenital Diseases
- +3 more
- SoracteLite(TM) TPLA for BPH
-
Hialeah, FloridaUrology Specialist Group
Jan 24, 2023
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)
Not yet recruiting
- Cancer
- +5 more
- Ureteral Stent
- Percutaneous Nephrostomy Tube Placement
-
Chicago, IllinoisThe University of Chicago
Nov 28, 2022
Benign Prostatic Hyperplasia Trial in Helwan (transurethral bipolar enucleation and resection of the prostate, open surgical
Completed
- Benign Prostatic Hyperplasia
- transurethral bipolar enucleation and resection of the prostate
- open surgical transvesical prostatectomy
-
Helwan, EgyptHelwan university faculty of medicine
Jun 8, 2022
Cervical Cancer Trial (acupuncture)
Not yet recruiting
- Cervical Cancer
- acupuncture
- (no location specified)
Oct 16, 2023
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Bladder Neck Obstruction, Benign Prostate Hyperplasia Trial in Kfar Saba (Insertion of Temporary Implantable Nitinol Device
Completed
- Bladder Neck Obstruction
- Benign Prostate Hyperplasia
- Insertion of Temporary Implantable Nitinol Device (TIND)
-
Kfar Saba, IsraelMeir Medical center
Dec 19, 2018
Gynecologic Cancer, Skin Cancer, Head Neck Cancer Trial in Worldwide (Stereotactic body radiotherapy, Palliative RT)
Recruiting
- Gynecologic Cancer
- +14 more
- Stereotactic body radiotherapy
- Palliative RT
-
Gent, Belgium
- +6 more
May 9, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
